BackDevonian Health Group Overview

Devonian Health Group EBIT

Track Devonian Health Group's EBIT ($-11M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$1.94M
↓ 6307.21% YoY

As of Apr 30, 2026

Annual EBIT (TTM)

-$11.13M
↓ 1121.33% YoY

Trailing 12 months ending Apr 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Devonian Health Group (DVHGF) FAQ

The latest EBIT for DVHGF is $-11M as of April 2026. That compares with $1.1M in the prior-year period — down 1121.3% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Devonian Health Group's historical trend and sector peers before judging valuation or financial health.

Over the past year, DVHGF's EBIT moved from $1.1M to $-11M — a 1121.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Devonian Health Group's operating scale or balance-sheet position.

Against Healthcare companies, DVHGF currently prints $-11M for EBIT, while the sector average sits near $110B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Devonian Health Group's growth, margins, and balance sheet.

A EBIT figure of $-11M for DVHGF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting DVHGF's EBIT ($-11M), review year-over-year change from $1.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.